• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布尔格兔模型:向揭示血栓闭塞性脉管炎迈进的更近一步?

The Buerger's rabbit model: a closer step to unravelling thromboangiitis obliterans?

作者信息

Li Jia-Long, Kwan Kristine J S, Lin Xue-Guang, Wang Jie, Chen Bo, Lu Yi-Jie, Wang Bo, Xie Shi-Shuai, Zhou Jiong, Yu Bo, Deng Ying, Jiang Shuai, Tang Jing-Dong

机构信息

Department of Vascular Surgery, Fudan University Pudong Medical Center, Shanghai Key Laboratory of Vascular Lesions Regulation and Remodeling, Shanghai, 201399, China.

出版信息

Thromb J. 2024 Jul 29;22(1):69. doi: 10.1186/s12959-024-00638-z.

DOI:10.1186/s12959-024-00638-z
PMID:39075498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11285203/
Abstract

OBJECTIVE

Thromboangiitis obliterans (TAO) remains clinical challenging due to its rarity and underwhelming management outcomes. This study aimed to describe a novel TAO rabbit model that demonstrates a closer resemblance to TAO.

METHODS

Thirty-six New Zealand rabbits underwent the surgical implantation of calibrated gelatin sponge particles (CGSPs) into their right femoral artery. The CGSPs were soaked in different solutions to simulate different types of thrombi: normal (NT; normal saline); inflammatory TAO thrombus (TAO; dimethylsulfoxide [DMSO]), and DMSO with methotrexate (MTX). All groups underwent clinical assessment, digital subtraction angiography (DSA) and histopathological analysis at time points day 0 (immediate), week 1 (acute), week 2 (subacute), and week 4 (chronic).

RESULTS

The TAO rabbit presented with signs of ischemia of the right digit at week 4. On DSA, the TAO rabbits exhibited formation of corkscrew collaterals starting week 1. On H&E staining, gradual CGSP degradation was observed along with increased red blood cell aggregation and inflammatory cells migration in week 1. On week 2, disorganization of the tunica media layer and vascular smooth muscle cell (VSMC) proliferation was observed. In the TAO rabbit, migrated VSMCs, inflammatory cells, and extracellular matrix with collagen-like substances gradually occluded the lumen. On week 4, the arterial lumen of the TAO rabbit was filled with relatively-organized VSMC and endothelial cell clusters with less inflammatory cells. Neorevascularization was found in the MTX-treated group.

CONCLUSION

The novel TAO rabbit model shows a closer resemblance to human TAO clinically, radiographically, and histopathologically. Histological analysis of the IT progression in the TAO model suggests that it is of VSMC origin.

摘要

目的

血栓闭塞性脉管炎(TAO)因其罕见性及治疗效果不尽人意,在临床上仍具有挑战性。本研究旨在描述一种与TAO更为相似的新型TAO兔模型。

方法

36只新西兰兔接受手术,将校准的明胶海绵颗粒(CGSPs)植入其右股动脉。CGSPs浸泡在不同溶液中以模拟不同类型的血栓:正常(NT;生理盐水);炎性TAO血栓(TAO;二甲基亚砜[DMSO]),以及含甲氨蝶呤(MTX)的DMSO。所有组在第0天(即刻)、第1周(急性)、第2周(亚急性)和第4周(慢性)时间点接受临床评估、数字减影血管造影(DSA)和组织病理学分析。

结果

TAO兔在第4周出现右趾缺血迹象。在DSA上,TAO兔从第1周开始出现螺旋状侧支循环形成。在苏木精-伊红(H&E)染色中,第1周观察到CGSP逐渐降解,同时红细胞聚集增加和炎性细胞迁移。第2周,观察到中膜层紊乱和血管平滑肌细胞(VSMC)增殖。在TAO兔中,迁移的VSMC、炎性细胞和含有胶原样物质的细胞外基质逐渐阻塞管腔。第4周,TAO兔的动脉管腔充满相对有序的VSMC和内皮细胞簇,炎性细胞较少。在MTX治疗组中发现了新生血管形成。

结论

新型TAO兔模型在临床、影像学和组织病理学上与人类TAO更为相似。TAO模型中IT进展的组织学分析表明其起源于VSMC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/e144ec9fb79c/12959_2024_638_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/64ed60e71bbe/12959_2024_638_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/76ef3b0439d3/12959_2024_638_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/df2c8693dfa7/12959_2024_638_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/9c644673338f/12959_2024_638_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/e86c2431c83f/12959_2024_638_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/e144ec9fb79c/12959_2024_638_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/64ed60e71bbe/12959_2024_638_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/76ef3b0439d3/12959_2024_638_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/df2c8693dfa7/12959_2024_638_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/9c644673338f/12959_2024_638_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/e86c2431c83f/12959_2024_638_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc6/11285203/e144ec9fb79c/12959_2024_638_Fig6_HTML.jpg

相似文献

1
The Buerger's rabbit model: a closer step to unravelling thromboangiitis obliterans?布尔格兔模型:向揭示血栓闭塞性脉管炎迈进的更近一步?
Thromb J. 2024 Jul 29;22(1):69. doi: 10.1186/s12959-024-00638-z.
2
Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).血栓闭塞性脉管炎(伯格氏病)的血管内治疗
Vasc Endovascular Surg. 2018 Feb;52(2):124-130. doi: 10.1177/1538574417744085. Epub 2017 Dec 13.
3
Protective effect of Shenfu injection on thromboangiitis obliterans model rats.参附注射液对血栓闭塞性脉管炎模型大鼠的保护作用。
J Ethnopharmacol. 2011 Nov 18;138(2):458-62. doi: 10.1016/j.jep.2011.09.033. Epub 2011 Sep 29.
4
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.通过血管内皮生长因子肌肉内基因转移治疗血栓闭塞性脉管炎(伯格氏病):初步临床结果
J Vasc Surg. 1998 Dec;28(6):964-73; discussion 73-5. doi: 10.1016/s0741-5214(98)70022-9.
5
Alleviation of A disintegrin and metalloprotease 10 (ADAM10) on thromboangiitis obliterans involves the HMGB1/RAGE/ NF-κB pathway.ADAM10 对血栓闭塞性脉管炎的缓解涉及 HMGB1/RAGE/NF-κB 通路。
Biochem Biophys Res Commun. 2018 Oct 20;505(1):282-289. doi: 10.1016/j.bbrc.2018.09.002. Epub 2018 Sep 20.
6
The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease).血栓闭塞性脉管炎(伯格氏病)的兴衰与复苏
Acta Pathol Jpn. 1989 Mar;39(3):153-8. doi: 10.1111/j.1440-1827.1989.tb01494.x.
7
Circulating angiogenic factors in patients with thromboangiitis obliterans.血栓闭塞性脉管炎患者的循环血管生成因子。
PLoS One. 2012;7(4):e34717. doi: 10.1371/journal.pone.0034717. Epub 2012 Apr 10.
8
Integration of traditional Chinese medicine and nibble debridement and dressing method reduces thrombosis and inflammatory response in the treatment of thromboangiitis obliterans.中医与蚕食清创换药法相结合在血栓闭塞性脉管炎治疗中可减轻血栓形成及炎症反应。
Ann Transl Med. 2021 Sep;9(18):1413. doi: 10.21037/atm-21-3752.
9
Thromboangiitis Obliterans (Buerger's Disease).血栓闭塞性脉管炎(伯格氏病)。
Curr Treat Options Cardiovasc Med. 2000 Jun;2(3):205-212. doi: 10.1007/s11936-000-0014-1.
10
A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease).一项关于血栓闭塞性脉管炎(伯格氏病)患者烟草依赖的前瞻性病例对照研究。
Angiology. 2006 Jan-Feb;57(1):73-8. doi: 10.1177/000331970605700110.

本文引用的文献

1
Animal experimental models of ischemic limbs - A systematic review.缺血肢体的动物实验模型——一项系统综述。
Vascul Pharmacol. 2023 Dec;153:107237. doi: 10.1016/j.vph.2023.107237. Epub 2023 Oct 5.
2
Recent advances of oxidative stress in thromboangiitis obliterans: biomolecular mechanisms, biomarkers, sources and clinical applications.血栓闭塞性脉管炎氧化应激的最新进展:生物分子机制、生物标志物、来源及临床应用。
Thromb Res. 2023 Oct;230:64-73. doi: 10.1016/j.thromres.2023.08.015. Epub 2023 Aug 25.
3
Lotus Root-Like Appearance at the Radial Artery in a Buerger-Like Disease Patient.
一名血栓闭塞性脉管炎样疾病患者桡动脉出现莲藕样外观。
JACC Cardiovasc Interv. 2023 Sep 11;16(17):2183-2184. doi: 10.1016/j.jcin.2023.06.036. Epub 2023 Aug 9.
4
Integrated pharmacokinetics and pharmacometabolomics to reveal the synergistic mechanism of a multicomponent Chinese patent medicine, Mailuo Shutong pills against thromboangiitis obliterans.综合药代动力学和代谢组学揭示脉络通片治疗血栓闭塞性脉管炎的协同作用机制。
Phytomedicine. 2023 Apr;112:154709. doi: 10.1016/j.phymed.2023.154709. Epub 2023 Feb 8.
5
DMSO-soluble smoking particles up-regulate the vascular endothelin receptors through AMPK-SIRT1 and MAPK pathways.二甲基亚砜可溶吸烟颗粒通过 AMPK-SIRT1 和 MAPK 通路上调血管内皮素受体。
Chem Biol Interact. 2022 Dec 1;368:110203. doi: 10.1016/j.cbi.2022.110203. Epub 2022 Sep 30.
6
Mechanisms of fibrinolysis resistance and potential targets for thrombolysis in acute ischaemic stroke: lessons from retrieved stroke emboli.急性缺血性脑卒中溶栓抵抗的机制及潜在靶点:取自脑卒中栓子的经验教训。
Stroke Vasc Neurol. 2021 Dec;6(4):658-667. doi: 10.1136/svn-2021-001032. Epub 2021 Jul 26.
7
Thrombus Structural Composition in Cardiovascular Disease.心血管疾病中的血栓结构组成
Arterioscler Thromb Vasc Biol. 2021 Sep;41(9):2370-2383. doi: 10.1161/ATVBAHA.120.315754. Epub 2021 Jul 15.
8
Interplay between inflammation and thrombosis in cardiovascular pathology.心血管病理学中的炎症与血栓形成的相互作用。
Nat Rev Cardiol. 2021 Sep;18(9):666-682. doi: 10.1038/s41569-021-00552-1. Epub 2021 May 6.
9
Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO).低分子量肝素(LMWH)与华法林用于血栓闭塞性脉管炎(TAO)的抗凝治疗效果
Curr Vasc Pharmacol. 2021;19(6):655-662. doi: 10.2174/1570161119666210118125424.
10
Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.胆碱激活 M3AChR(M3 型毒蕈碱乙酰胆碱受体)和 Nrf2(核因子红细胞 2 相关因子 2)信号通路可减轻血管平滑肌细胞表型转化和血管重构。
Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2649-2664. doi: 10.1161/ATVBAHA.120.315146. Epub 2020 Sep 17.